title: Spontaneous recovery of severe nilotinib-induced bone marrow aplasia and successful retreatment with dasatinib in a patient with Chronic Phase Chronic Myeloid Leukemia.
authors: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic , Cleveland, OH , USA.
authors: Fayez
authors: F
authors: Estephan
authors: Heesun J
authors: HJ
authors: Rogers
authors: Valeria
authors: V
authors: Visconte
authors: Ali
authors: A
authors: Tabarroki
authors: Jing
authors: J
authors: Ai
authors: Hien K
authors: HK
authors: Duong
authors: Matt
authors: M
authors: Kalaycio
authors: Ramon V
authors: RV
authors: Tiu
mesh_terms: D001855:Bone Marrow Diseases / Q000139:chemically induced*; D001856:Bone Marrow Examination / Q000379:methods; D000069439:Dasatinib / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy*; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000009:adverse effects*; D012075:Remission, Spontaneous
chemical_list: D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D011505:Protein-Tyrosine Kinases; C498826:nilotinib; D000069439:Dasatinib